• ABOUT
    Corporate Overview Management Team
  • PLATFORM
    About eLEAD Technical Advantage
  • RESEARCH
    Therapeutic Focus PIPELINE
  • NEWS
  • CAREER
    Culture Values Jobs
  • INVESTORS
cn
  • INDEX
  • ABOUT
  • PLATFORM
  • RESEARCH
  • NEWS
  • CAREER
  • INVESTORS

NEWS & MEDIA COVERAGE

News Center

  • 2024-12-11

    Artivila Biopharma Announces Clearances of IND Applications for ARD-885 by Chine

    ShenZhen, Guangdong, China. December 11, 2024- Artivila Biopharma today announced that the Chinese NMPA and the United States FDA have approved its IND applications for its small molecule new drug ARD-885 for the treatment of rheumatoid arthritis.

    Read more
  • About Platform Research News
  • Career Contact  Investors

Contact us

  • Phone: 0755-23779972
  • Address: 2nd Floor, Building 3, Longcheng Industrial Park, Longgang District, Shenzhen, Guangdong Province
  • Postal Code: 518172
  • Email: info@artivilatx.com

Social Media

Copyright © 2020-2030 ARTIVILA. ALL RIGHTS RESERVED.  粤ICP备2021130543号